Abstract
Recently, the development of radiotherapy technology and to radiation-induced heart disease in patients with esophageal cancer. Investigations using chemotherapy has improved treatment results for esophageal cancer, and attention has been paidSEER for esophageal cancer showed that the hazard ratio of heart-related death was 1.62–1.96. Herein we review published literature regarding the mechanism of and countermeasures for radiation-induced heart disease and discuss the potential of concurrent chemotherapy, molecular-targeted agents and lifestyle for exacerbating radiation-induced heart disease.
| Original language | English |
|---|---|
| Pages (from-to) | 215-220 |
| Number of pages | 6 |
| Journal | Esophagus |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2017 Jul 1 |
Keywords
- Molecular-targeted agent
- Radiation-induced arrhythmia
- Radiation-induced heart disease
- Radiation-induced myocardial disease
ASJC Scopus subject areas
- Gastroenterology
UN SDGs
This output contributes to the following Sustainable Development Goal(s)
